feussner7

References

1. Sannerud, C. and Feussner, G. Is methylphenidate a Schedule II stimulant? In: Ritalin: Theory and Practice, 2nd edition, Osman, B. and Greenhill, L. (eds.). Mary Ann Liebert, Inc. (In press).
2. Huang, J.T. and Ho, B.T. Discriminative stimulus properties of d-amphetamine and related compounds in rat. Pharmacol Blochem Behav. 1974;2:669-673.
3. Porsolt, R.D., Pawelec, C., and Jalfre, M. Use of drag discrimination procedures to detect amphetamine-like effects of antidepressants. In: Drug Discrimination: Applications in CNS Pharmacology. Colpaert, F.C. and Slangen, J.L. (eds.). Elsevier Biomedical Press: Amsterdam. 1982; 193-202.
4. Rosen, J.R., Young, A.M., Beuthin, F.C. and Louis-Ferdinand, R.T. Discriminative stimulus properties of amphetamine and other stimulants in lead-exposed and normal rats. Pharmacol Blochem Behav. 1986; 24:211-215.
5. Evans, S.E. and Johanson, C.E. Amphetamine-like effects of anorectic and related compounds in pigeons. ,1 Pharmacol Exp Ther. 1987;241:817-825.
6. De la Garza and Johanson, C.E. Discriminative stimulus properties ofintragastrically administered d-amphetamine and pentobarbital in rhesus monkeys. JPharmacol Exp Ther. 1987;243'955-962.
7. Colpaert, F.C., Niemegeers, C.J.E., and Janssen, P.A.J. Discriminative stimulus properties of cocaine: Neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacol Blochem Behav. 1979;10:535-546.
8. McKe~, M.L. and Ho, B.T. The role of clopamine in the discriminative stimulus properties of cocaine. Neuro�harmacol. 1980;19:297-303.
9. Emmett-Oglesby, M.W., Wurst, M., and Lal, H. Discriminative stimulus properties of a small dose of cocaine. Neuropharmacol. 1983;22:97-101.
10. Wood, D.M. and Emmett-Oglesby, M.W. Substitution and cross-tolerance profiles of anorectic drugs in rats trained to detect the discriminative stimulus properties of cocaine. Psychopharmacol. 1988;95:364-368.
11. Silverman, P.B., and Sehnltz, K.A. Comparison of cocaine and procaine discriminative stimuli. Drug Dev Res. 1989;16:427-433.
12. Perkins, A.N., Eckerman, D.A., and McPhail, R.C. Discriminative stimulus properties of triadimefon: Comparison with methylphenidate. Pharmacol Blochem Behav. 1991;40:757-761. 13. Overton, D.A. Comparison of the degree of discriminability of various drugs using a T-maze drug discrimination paradigm. Psychopharmacol. 1982;76:385-395.
14. Martin, W.R., Sloan, J.W., Sapira, J.D., and Jasinski, D.R. Physiological, subjective, and behavioral effect of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther. 1971;12:245-258.
15. Huey, L.Y., Janowsky, D.S., Judd, L.L., Roitman, N.A., Clopton, P.L., Segal., D., Hall, L., and Parker, D. The effects of naloxone on methylphenidate-induced mood and behavioral changes: A negative study. Psychopharmacol. 1980;67:125-130.
16. Chait, L.D. Reinforcing and subjective effects of methylphenidate in humans. Behav Pharmacol. 1994;5:281-288.
17. Brown, W.A. Psychologic and neuroendocrine response to methylphenidate. Arch Gen Psychiatry. 1977;34:1103-1108.
18. Brown, W.A., Corriveau, D.P. and Ebert, M.H. Acute psychologic and neuroendoerine effects of dextroamphetamine and methylphenidate. Psychopharmacol. 1978;58:189-195.
19. Smith, R.C. and Davis, J.M. Comparative effects of d-amphetamine, 1-amphetamine, and methylphertidate on mood in man. Psychopharmacol. 1977;53:1-12.
20. Wilson, M.C., Hitomi, M. and Schuster, C.R. Psychomotor stimulant self-administration as a function of dosage per injection in the rhesus monkey. Psychopharmacol. 1971;22:271-281.
21. Wilson, M.C. and Schuster, C.R. The effects of chlorpromazine on psychomotor stimulant self-administration in the rhesus monkey. Psychopharmacol. (Bed.) 1972;26:115-126.
22. Aigner, T.G. and Balster, R.L. Rapid substitution procedure for intravenous drug self-administration studies in rhesus monkeys. Pharmacol Blochem Behav~ 1979;10:105-112.
23. Spealman, R.D., Madras, B.K., and Bergman, J. Effects of cocaine and related drugs in
non-human primates. II. Stimulant effects on schedule controlled behavior, dPharmacol Exp Ther. 1989;251:142-1459.
24. Nietsen, J.A., Duda, N.J., Mokler, D.I., and Moore, K.E. Self-administration of central stimulants by rats: A comparison of the effects of d-amphetamine, methylphenidate and McNeil4612. Pharmacol Biochem Behav. 1984;20:227-232.
25. Risner, M.E. and Jones, B.E. Self-administration of CNS stimulants by dogs. Psychopharmacol. 1975;43:207-213.
26. Risner, M.E. and Jones, B.E. Characteristics of unlimited access to self-administered stinmlant infusion in dogs. Bio Psych. 1976; 11:625-634.
27. Downs, D.A., Hardgan, S.E., Wiley, J.N., Robinson, T.E., and Labay, R.J. Research Communications in Psychology. Psych Behav. 1979;4: 39-49.
28. Collins, R.J., Weeks, J.R. Cooper, M.M., Good, P.I., and Russell, R.R. Prediction of abuse liability of drags using IV self-administration by rats. Psychopharmacol. 1984;82:6-13.
29. Dworldn, S.I., Vrana, S.L., Broadbent, J., and Robinson, J.H. Comparing the reinforcing effects of nicotine, caffeine, methylphenidate and cocaine. Med Chem Res. 1993;2:593-602.
30. Johanson, C.E. and Schuster, C.R. A choice procedure for drug reinforcers: Cocaine and methylphenidate in the rhesus monkey, dPharmacol Exp Ther. 1975;193:676-688.